<DOC>
	<DOCNO>NCT02811302</DOCNO>
	<brief_summary>PRODIGY prospective , multi-center , post-market , international cohort study . The primary objective study derive score identify subject risk respiratory depression ( RD ) episodes patient undergo opioid therapy hospital ward monitor capnography . The score derive use subject within derivation cohort internally validate use subject within validation cohort . The primary endpoint use derive score occurrence RD episodes derive Capnostream 20p device memory data combine clinical data validate independent Clinical Endpoint Committee ( CEC ) study course .</brief_summary>
	<brief_title>PRediction Opioid-induced Respiratory Depression In Patients Monitored capnoGraphY</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>1 . Patients receive parenteral opioid therapy ( postsurgical nonsurgical ) pain hospital ward . 2 . Adult age ( ≥18 year old US Europe ; ≥20 year old Japan ; ≥21 year old Singapore ) . 3 . Patient able willing give inform consent . 1 . Expected length stay ≤ 24 hour . 2 . Patient receive intrathecal opioids . 3 . Postsurgical patient American Society Anesthesiologists physical status ( ASA PS ) V high . 4 . Patients status Do Not Resuscitate ( DNR ) , hospice , receive end life therapy . 5 . Ventilated intubated patient . 6 . Patient unwilling unable comply fully study procedure ( include nontoleration capnography cannula ) due disease condition raise doubt compliance influence study outcome . 7 . Patient member vulnerable population , include legal incapacity evidence subject understand purpose risk study , regardless authorize representative support . 8 . Patient participate another potentially confound drug device clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>